Ivannah Tobias
NoneQuezon City, Philippines
SEARCH RESULTS
331395 RESULTS
PAPER Gilerovich EG, Manina AA, Ivonin AA
Ultrastructural characteristics of the neuron during functional activity [proceedings].
Folia Morphol (Praha). 1977 Jan 1;25(3):249-55. PubMed: 885431Miami: Age and Amyloid—What Has ApoE Got to Do With It?
CONFERENCE COVERAGE 2012-03-02 Conference Coverage At this stage of Alzheimer's disease research, scientists know that APP or presenilin mutations and the risk gene ApoE4 have two things in common. Both bring down the carrier’s age of disease onset, ApoE4 less drastically than the
Research Brief: Is Rare Amyloid Disorder Autoimmune Disease?
RESEARCH NEWS 2012-03-02 Research News In a rare condition known as amyloid-β-related angiitis (ABRA), buildup of amyloid in the brain vasculature (cerebral amyloid angiopathy) is accompanied by swelling in the small- and medium-sized arteries of the cortices and in the membranes
Astrocyte ATP, Transmembrane Chemokine Drive Neuroprotection
RESEARCH NEWS 2012-03-02 Research News Astrocytes—the star-shaped cells that support neurons in the brain—seem two-faced. While they can trigger harmful neuroinflammation, astrocytes also secrete molecules that may help curb that destruction. Two papers in this week’s Journal of
PAPER Schroeter ML
Considering the frontomedian cortex in revised criteria for behavioural variant frontotemporal dementia.
Brain. 2012 Apr;135(Pt 4):e213; author reply e214. PubMed: 22362608PAPER Witt K, Deuschl G, Bartsch T
[Frontotemporal dementias.]
Nervenarzt. 2012 Feb 26; PubMed: 22366755PAPER Taipa R, Tuna A, Damásio J, Pinto PS, Cavaco S, Pereira S, Milterberger-Miltenyi G, Galimberti D, Melo-Pires M
Clinical, Neuropathological, and Genetic Characteristics of the Novel IVS9+1delG GRN Mutation in a Patient with Frontotemporal Dementia.
J Alzheimers Dis. 2012 Jan 1;30(1):83-90. PubMed: 22366770PAPER Hodges J
Familial frontotemporal dementia and amyotrophic lateral sclerosis associated with the C9ORF72 hexanucleotide repeat.
Brain. 2012 Mar;135(Pt 3):652-5. PubMed: 22366789PAPER Camilloni C, De Simone A, Vranken WF, Vendruscolo M
Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts.
Biochemistry. 2012 Mar 20;51(11):2224-31. PubMed: 22360139PAPER Corrochano S, Renna M, Tomas-Zapico C, Brown SD, Lucas JJ, Rubinsztein DC, Acevedo-Arozena A
α-Synuclein levels affect autophagosome numbers in vivo and modulate Huntington disease pathology.
Autophagy. 2012 Mar 1;8(3) PubMed: 22361581PAPER Kachroo A, Schwarzschild MA
Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease.
Ann Neurol. 2012 Feb;71(2):278-82. PubMed: 22367999PAPER Foulds P, Mann DM, Allsop D
Phosphorylated α-synuclein as a potential biomarker for Parkinson's disease and related disorders.
Expert Rev Mol Diagn. 2012 Mar;12(2):115-7. PubMed: 22369370PAPER Lue LF, Walker DG, Adler CH, Shill H, Tran H, Akiyama H, Sue LI, Caviness J, Sabbagh MN, Beach TG
Biochemical Increase in Phosphorylated Alpha-Synuclein Precedes Histopathology of Lewy-Type Synucleinopathies.
Brain Pathol. 2012 Feb 27; PubMed: 22369130PAPER Yan SQ, Sun JZ, Yan YQ, Wang H, Lou M
Evaluation of brain iron content based on magnetic resonance imaging (MRI): comparison among phase value, R2* and magnitude signal intensity.
PLoS One. 2012;7(2):e31748. PubMed: 22363719Current Filters
No filters selected